CIK 0001438943 · Non-accelerated filer<br>Smaller reporting company
RANGE IMPACT, INC.
Sign in to watch- Ticker
- RNGE
- Exchange
- OTC
- Industry
- Heavy Construction Other Than Bldg Const - Contractors
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 753268988
- Phone
- 530-231-7800
- Business address
- 200 PARK AVENUE, SUITE 400, CLEVELAND, OH, 44122
- Former names
- MALACHITE INNOVATIONS, INC., Vitality Biopharma, Inc., Stevia First Corp., Legend Mining Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-04-28 | FEIGHAN EDWARD F Director | Purchase | +30,000 | $0.20 | $6K | 2,389,022 |
| 2023-04-26 | FEIGHAN EDWARD F Director | Purchase | +2,000 | $0.20 | $400 | 2,359,022 |
| 2023-04-25 | FEIGHAN EDWARD F Director | Purchase | +2,000 | $0.20 | $390 | 2,357,022 |
| 2023-04-21 | FEIGHAN EDWARD F Director | Purchase | +5,000 | $0.20 | $994 | 2,345,022 |
| 2023-04-21 | FEIGHAN EDWARD F Director | Purchase | +10,000 | $0.20 | $2K | 2,355,022 |
| 2023-04-19 | FEIGHAN EDWARD F Director | Purchase | +1,000 | $0.18 | $185 | 2,340,022 |
| 2023-04-11 | FEIGHAN EDWARD F Director | Purchase | +333,333 | $0.15 | $50K | 2,339,022 |
| 2023-04-11 | FEIGHAN EDWARD F Director | Purchase · Common Stock Purchase Warrant (right to buy) | +333,333 | 1,583,333 | ||
| 2022-05-10 | LoConti Joseph E. 10% owner | Purchase | +6,666,667 | $0.15 | $1.0M | 12,797,146 |
| 2022-05-10 | LoConti Joseph E. 10% owner | Grant or award · Warrant | +6,666,667 | 6,666,667 | ||
| 2021-12-10 | FEIGHAN EDWARD F Director | Grant or award · Stock Option (Right to Buy) | −250,000 | 250,000 | ||
| 2021-12-10 | Cavanaugh Michael R. Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | −350,000 | 350,000 | ||
| 2021-12-10 | Celeste Richard F Director | Grant or award · Stock Option (Right to Buy) | −250,000 | 250,000 | ||
| 2021-12-10 | Zipp Brandon Joel Chief Science Officer | Returned to the company · Stock Option (Right to Buy) | −2,500 | 0 | ||
| 2021-12-10 | Zipp Brandon Joel Chief Science Officer | Returned to the company · Stock Option (Right to Buy) | −7,500 | 0 | ||
| 2021-12-10 | Zipp Brandon Joel Chief Science Officer | Returned to the company · Stock Option (Right to Buy) | −15,000 | 0 | ||
| 2021-12-10 | Zipp Brandon Joel Chief Science Officer | Returned to the company · Stock Option (Right to Buy) | −20,000 | 0 | ||
| 2021-12-10 | Zipp Brandon Joel Chief Science Officer | Returned to the company · Stock Option (Right to Buy) | −20,000 | 0 | ||
| 2021-12-10 | Zipp Brandon Joel Chief Science Officer | Returned to the company · Stock Option (Right to Buy) | −75,000 | 0 | ||
| 2021-12-10 | Zipp Brandon Joel Chief Science Officer | Grant or award · Stock Option (Right to Buy) | +127,487 | 127,487 |
Page 3 of 7 · 129 trades